The Costs of Loneliness-related Health Consequences in Spain
Papon, V., Puntscher, S., Arvandi, M., Jahn, B., Coll-Planas, L., Litt, J.,…Rochau, U. (2024). The Costs of Loneliness-related Health Consequences … Read More
Papon, V., Puntscher, S., Arvandi, M., Jahn, B., Coll-Planas, L., Litt, J.,…Rochau, U. (2024). The Costs of Loneliness-related Health Consequences … Read More
Bailón, L., Moltó, J., Curran, A., Cadiñanos, J., de Quirós, J., de los Santos, I.,…Brander, C., Mothe, B., Grp, A.-S. … Read More
Nuciforo, P., Navarro, F., Argota, I., Alonso, L., Serna, G., Barrull, J.,…Aguado, V. (2024). Intratumoral fusobacterium as prognostic factor in … Read More
Dienstmann, R., Ruiz-García, E., Alsina, M., Ruiz-Pace, F., Schooten, T., Martínez-Ciarpaglini, C.,…Fleitas, T. (2025). Integrated clinico-molecular analysis of gastric cancer … Read More
Cruz-Correa, M., Oh, D., Kato, K., Tabernero, J., Bai, Y., Shi, J.,…Moehler, M. (2024). Tislelizumab (TIS) plus chemotherapy (CT) vs … Read More
Perlas, A., Reska, T., Croville, G., Tarrés-Freixas, F., Guérin, J., Majó, N., & Urban, L. (2025). Improvements in RNA and … Read More
Tabernero, J., Yoshino, T., Kim, T., Yaeger, R., Desai, J., Wasan, H.,…Kopetz, S. (2024). Encorafenib plus cetuximab (EC) plus FOLFIRI … Read More
Amb la publicació recent de l’Action Plan for Open Repositories 2025, un full de ruta impulsat per COAR, OpenAIRE, LIBER … Read More
Parladé, E., Tarrés-Freixas, F., Favaro, M. T. P., Lascorz, J., Márquez-Matínez, M., Mendoza, R., Corchero, J. L., Cantero, G., Roca, … Read More
Fort-Vanmeerhaeghe, A, Pujol-Marzo, M, Milà, R, Campos, B, Nevot-Casas, O, Casadevall-Sayeras, P, Peña, J (2025). Injury Risk and Overall Well-Being … Read More